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ABSTRACT 
Background: Tuberculosis is one of the most common and deadliest infectious diseases 
worldwide affecting almost a third of the world's population. Although this disease is being 
prevented and controlled by the Bacille Calmette Guérin (BCG) vaccine, the protective efficacy 
is highly variable and substandard (0-80%) in adults. Therefore, novel and effective 
tuberculosis vaccine that can overcome the limitations from BCG vaccine need to be 
developed. Results: A novel approach of utilizing an in-trans protein surface display system of 
Lactobacillus plantarum carrying and displaying combination of Mycobacterium tuberculosis 
subunit epitope antigens (Ag85B, CFP-10, ESAT-6, Rv0475 and Rv2031c) fused with LysM 
anchor motif designated as ACERL was constructed, cloned and expressed in Esherichia coli 
Rossetta expression host. Subsequently the binding capability of ACERL to the cell wall of L. 
plantarum was examined via the immunofluorescence microscopy and whole cell ELISA 
where successful attachment and consistent stability of cell wall binding up to 4 days was 
determined. The immunization of the developed vaccine of L. plantarum surface displaying 
ACERL (Lp ACERL) via the oral route was studied in mice for its immunogenicity effects. Lp 
ACERL immunization was able to invoke significant immune responses that favor the Th1 
type cytokine response of IFN-γ, IL-12 and IL-2 as indicated by the outcome from the cytokine 
profiling of spleen, lung, gastrointestinal tract (GIT), and the re-stimulation of the splenocytes 
from the immunized mice. Co-administration of an adjuvant consisting of Lactococcus lactis 
secreting mouse IL-12 (LcIL-12) with Lp ACERL was also investigated. It was shown that the 
addition of LcIL-12 was able to further generate significant Th1 type cytokines immune 
responses, similar or better than that of Lp ACERL alone which can be observed from the 
cytokine profiling of the immunized mice's spleen, lung and GIT. Conclusions: This study 
represents a proof of concept in the development of L. plantarum as a carrier for a non-
genetically modified organism (GMO) tuberculosis vaccine, which may be the strategy in the 
future for tuberculosis vaccine development. 
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